Breast Cancer | Tumor

Breast Implants: Is There an Ideal Smoothness to Prevent Immune Reactions?

June 28th 2021, 1:00pm


Recent research found that breast implants with a specific texture tended to result in a lower level of inflammation and immune reactions than other implants.

Ibrance Plus Faslodex May Improve Long-Term Survival for Advanced Breast Cancer

June 23rd 2021, 6:00pm


The survival benefit obtained with Ibrance plus Faslodex persisted over a median follow-up of 73.3 months in patients with HR-positive, HER2-negative advanced breast cancer.

A Milkshake and Metastatic Cancer

June 20th 2021, 6:00pm


A man with breast cancer recalls his introduction to cancer as a child.

Novel 4-Drug Combo Significantly Improves Treatment Responses in Group of Patients with Breast Cancer

June 15th 2021, 6:00pm


Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.

Initial Diagnosis of Triple-Negative Breast Cancer

June 15th 2021, 12:32pm


Latasha Jordan, a triple-negative breast cancer survivor, discusses challenges she faced with her symptoms and diagnosis, and Aditya Bardia, M.D., MPH, reviews the typical diagnostic work-up used to determine a treatment approach.

Breast Cancer Care for the Incarcerated

June 11th 2021, 4:00pm


“All women with breast cancer deserve quality health care,” writes one survivor. “But for an incarcerated woman, that care may not come in a timely manner, if at all.”

Friday Frontline: Singer With Cancer Receives Golden Buzzer on ‘America’s Got Talent,’ Breast Cancer Survivor Launches Medical Wig Company for Curly and Coily Hair and More

June 11th 2021, 3:00pm


From an emotional "America’s Got Talent” audition from a singer with cancer to a wig company that creates wigs for women of color, here’s what’s happening in the cancer landscape this week.

Trodelvy Associated with Better Benefits Than Chemo in Metastatic Triple-Negative Breast Cancer, Regardless of Agent

June 9th 2021, 3:00pm


The data, according to the study’s lead author, confirm that Trodelvy should be considered a new standard of care in patients with metastatic triple-negative breast cancer.

Patients with Early Triple-Negative Breast Cancer May Benefit from Imfinzi-Neoadjuvant Chemo Combo

June 8th 2021, 5:00pm


Patients with early triple-negative breast cancer receiving Imfinzi in addition to neoadjuvant chemotherapy saw increased survival rates and complete responses to treatment.

Lynparza Following Standard of Care Treatments Effective in Some Patients with High-Risk Breast Cancer

June 5th 2021, 2:00pm


Some patients with early HER2-negative breast cancer at high risk for disease recurrence achieved meaningful benefit with Lynparza after receiving standard of care therapies, such as surgery or chemotherapy.